SCHEMBL1553846

SCHEMBL1553846

CCOC(=O)c1sc(Cl)nc1C(=O)NCCOC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
CYP1A2 P05177 2/20 0.45
HPGD P15428 5/20 0.43
MAPK1 P28482 2/20 0.43
CYP2C19 P33261 1/20 0.42
HTT P42858 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CHRM4 P08173 1/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
NPC1 O15118 1/20 0.39
KIFC1 Q9BW19 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FBP1 P09467 1/20 0.38
MAPT P10636 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1553279 0.90 ALDH1A1 (0.47) ALDH1A1CYP1A2HPGDHTTTP53
SCHEMBL1553587 0.87 ALDH1A1 (0.45) ALDH1A1CYP1A2HPGDHTTL3MBTL1
SCHEMBL1554058 0.87 ALDH1A1 (0.49) ALDH1A1CYP1A2HPGDHTTCHRM4
SCHEMBL3618097 0.85 KDM4E (0.41) ALDH1A1CYP1A2HPGDMAPK1CYP2C19
SCHEMBL1552951 0.84 ALDH1A1 (0.42) ALDH1A1CYP1A2HPGDHTTTP53
SCHEMBL27766727 0.84 HPGD (0.45) ALDH1A1CYP1A2HPGDMAPK1CYP2C19
SCHEMBL1505552 0.80 ALDH1A1 (0.66) ALDH1A1CYP1A2HPGDGAARAB9A
SCHEMBL1553145 0.80 SMN1; SMN2 (0.48) ALDH1A1CYP1A2HPGDHTTCHRM4
SCHEMBL1552481 0.80 ALDH1A1 (0.53) ALDH1A1CYP1A2HPGDMAPK1HTT
SCHEMBL1553485 0.79 ALDH1A1 (0.47) ALDH1A1CYP1A2HPGDHTTCHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2226322-B1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-01-21 EP disclosed
US-8927588-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-01-06 US disclosed
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-03-13 US disclosed
US-8536197-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-09-17 US disclosed
EP-2102199-B1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2011-04-27 EP disclosed
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-12-09 US disclosed
US-20100286181-A1 PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY ASTRAZENECA AB (SE) 2010-11-11 US disclosed
EP-2226322-A1 IMIDAZOLE CARBONYL COMPOUND Daiichi Sankyo Company, Limited (JP) 2010-09-08 EP disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286181-A1 PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY PGLS, UROD, GMPS ALDH1A1 1828/4885CYP1A2 907/4885HPGD 278/4885
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A ALDH1A1 3596/4885CYP1A2 2031/4885HPGD 1751/4885
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A ALDH1A1 1220/4885CYP1A2 545/4885HPGD 578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.